Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › LA › Shreveport › NPI 1568461572
Hospital

Willis Knighton Medical Center, INC.

Willis Knighton Medical Center, INC. was paid $76.23M by Medicaid between Jan 2018 and Dec 2024, across 255 billing codes. Its largest line is 99283, emergency room visit (moderate) — 23% of everything it billed.

33Billing provider infoWILLIS KNIGHTON MEDICAL CENTER, INC.
SHREVEPORT, LA 71103
33aNPI1568461572assigned 07/20/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$76.23M
24GClaims2,198,175
24DCodes billed255
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Louisiana

Rank by total paid#5 of 96
Median peer was paid$5.17M
This provider vs. median15×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018256,474$7.21M
2019285,423$8.57M
2020229,984$8.28M
2021326,403$13.87M
2022379,796$14.52M
2023415,056$13.72M
2024incomplete305,039$10.05M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 23% 183,462 169,918 $17.72M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 21% 94,011 86,548 $16.08M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 9.2% 40,745 37,367 $6.98M
99282 Emergency department visit for the evaluation and management, low to moderate severity 6.9% 72,190 67,796 $5.23M
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 4.9% 48,787 44,139 $3.77M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 4.1% 47,930 43,063 $3.13M
71045 Radiologic examination, chest; single view 4.1% 60,742 55,543 $3.11M
74176 Computed tomography, abdomen and pelvis; without contrast material 2.0% 2,876 2,596 $1.50M
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.9% 54,131 48,773 $1.43M
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis 1.5% 3,503 1,998 $1.14M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.3% 190,385 163,603 $1.01M
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 23,980 21,468 $747K
243 more codes
71046 Radiologic examination, chest; 2 views <1% 11,599 $655K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 11,039 $654K
70450 Computed tomography, head or brain; without contrast material <1% 4,210 $651K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 1,132 $608K
J3490 Unclassified drugs <1% 156,259 $605K
80053 Comprehensive metabolic panel <1% 79,996 $556K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 16,598 $513K
G0378 Hospital observation service, per hour <1% 5,188 $491K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 14,606 $460K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 14,614 $460K
36415 Collection of venous blood by venipuncture <1% 217,478 $458K
80048 Basic metabolic panel (calcium, ionized) <1% 67,761 $404K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 1,202 $403K
J8499 Prescription drug, oral, non chemotherapeutic, nos <1% 159,561 $395K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 18,562 $391K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 6,659 $354K
84703 <1% 53,992 $343K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 4,291 $307K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 8,379 $263K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 11,398 $258K
87631 <1% 2,091 $252K
83880 <1% 10,230 $214K
81001 <1% 77,527 $186K
87581 <1% 5,805 $183K
87486 <1% 5,793 $182K
80050 General health panel <1% 5,032 $174K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 32,981 $165K
84484 <1% 22,794 $164K
96375 Therapeutic injection; each additional sequential IV push <1% 3,609 $161K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 8,476 $157K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 3,285 $151K
83690 <1% 30,055 $150K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,903 $143K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 6,449 $142K
80061 Lipid panel <1% 10,007 $109K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 281 $108K
86780 <1% 8,298 $105K
80076 <1% 18,320 $102K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 6,794 $100K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 216 $92K
41899 Unlisted procedure, dentoalveolar structures <1% 347 $92K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 621 $90K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 21,783 $87K
87086 Culture, bacterial; quantitative colony count, urine <1% 11,587 $81K
76830 Ultrasound, transvaginal <1% 435 $72K
99218 <1% 1,238 $71K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants <1% 810 $67K
83036 Hemoglobin; glycosylated (A1C) <1% 8,905 $66K
97602 <1% 3,554 $66K
83735 <1% 16,281 $58K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 17,104 $58K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 3,003 $56K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 947 $56K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 205 $45K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 2,017 $40K
76775 <1% 221 $39K
86803 <1% 2,757 $38K
87340 <1% 3,732 $37K
86762 <1% 2,556 $35K
J7050 Infusion, normal saline solution, 250 cc <1% 1,801 $34K
87390 <1% 1,568 $33K
C1776 Joint device (implantable) <1% 14 $32K
J9271 Injection, pembrolizumab, 1 mg <1% 22 $32K
84443 Thyroid stimulating hormone (TSH) <1% 2,475 $30K
84439 <1% 3,980 $29K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 6,880 $27K
92557 <1% 415 $26K
86738 <1% 2,052 $25K
86003 <1% 806 $22K
86300 <1% 1,603 $22K
87150 <1% 680 $22K
96417 <1% 259 $22K
86850 <1% 3,743 $22K
87070 <1% 3,333 $22K
83655 <1% 1,747 $21K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,556 $19K
81003 <1% 10,048 $18K
86702 <1% 1,566 $17K
84481 <1% 1,797 $16K
80069 <1% 5,892 $15K
86701 <1% 1,569 $15K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 143 $14K
84681 <1% 46 $14K
86787 <1% 1,053 $12K
J1453 Injection, fosaprepitant, 1 mg <1% 78 $12K
77067 Screening mammography, bilateral, including computer-aided detection <1% 222 $11K
80197 <1% 4,213 $11K
87081 <1% 1,376 $9K
86901 <1% 3,237 $9K
86900 <1% 3,239 $9K
82784 <1% 1,046 $8K
59025 Fetal non-stress test <1% 321 $8K
72100 <1% 156 $8K
83516 <1% 697 $8K
83605 <1% 1,058 $8K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 14 $7K
80074 <1% 237 $7K
96367 <1% 402 $7K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 560 $7K
83021 <1% 357 $7K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 1,062 $7K
86140 <1% 1,564 $6K
J1170 Injection, hydromorphone, up to 4 mg <1% 1,241 $6K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 16 $6K
97161 <1% 143 $6K
J0690 Injection, cefazolin sodium, 500 mg <1% 841 $6K
84702 <1% 485 $6K
85027 <1% 3,559 $6K
99223 Prolong inpt eval add15 m <1% 609 $6K
82607 <1% 492 $6K
82950 <1% 1,217 $5K
74019 <1% 110 $5K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 13 $5K
67311 <1% 19 $5K
51798 <1% 237 $5K
93296 <1% 548 $5K
J3475 Injection, magnesium sulfate, per 500 mg <1% 198 $5K
83020 <1% 357 $5K
J2704 Injection, propofol, 10 mg <1% 8,217 $4K
86364 <1% 834 $4K
82746 <1% 406 $4K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 30 $4K
74022 <1% 81 $4K
70210 <1% 44 $4K
74018 <1% 51 $4K
85610 <1% 1,546 $4K
J2550 Injection, promethazine hcl, up to 50 mg <1% 873 $4K
85730 <1% 993 $4K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 6,562 $4K
82962 <1% 1,538 $4K
73130 <1% 43 $4K
97162 <1% 74 $4K
83993 <1% 244 $3K
70355 <1% 234 $3K
82550 <1% 731 $3K
85652 <1% 1,465 $3K
85379 <1% 429 $3K
73560 <1% 26 $3K
96415 <1% 56 $3K
81002 <1% 772 $2K
J2270 Injection, morphine sulfate, up to 10 mg <1% 562 $2K
85660 <1% 478 $2K
80164 <1% 295 $2K
77063 Screening digital breast tomosynthesis, bilateral <1% 222 $2K
82785 <1% 161 $2K
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 151 $2K
82150 <1% 421 $2K
72040 <1% 46 $2K
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 721 $2K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 4,678 $2K
86696 <1% 104 $2K
72110 <1% 14 $2K
J8597 Antiemetic drug, oral, not otherwise specified <1% 61 $2K
84436 <1% 351 $2K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 75 $2K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 285 $2K
77336 <1% 27 $1K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 14 $1K
87077 <1% 555 $1K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 237 $1K
82728 <1% 155 $1K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 257 $1K
86695 <1% 104 $1K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 54 $1K
94644 <1% 14 $1K
J2469 Injection, palonosetron hcl, 25 mcg <1% 15 $1K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 28 $1K
J8540 Dexamethasone, oral, 0.25 mg <1% 246 $1K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 908 $988.53
87040 <1% 139 $972.46
J7510 Prednisolone oral, per 5 mg <1% 433 $969.59
83550 <1% 154 $952.31
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 27 $938.64
84146 <1% 51 $928.52
83540 <1% 198 $908.25
86480 <1% 18 $867.72
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 1,203 $791.36
J1596 Injection, glycopyrrolate, 0.1 mg <1% 994 $767.93
J9045 Injection, carboplatin, 50 mg <1% 15 $696.32
86255 <1% 57 $642.51
87186 <1% 279 $641.72
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 28 $631.29
82570 <1% 143 $591.85
81222 <1% 35 $557.61
86008 <1% 37 $554.08
84100 <1% 167 $552.43
17250 <1% 16 $524.88
87799 <1% 214 $505.75
87497 <1% 54 $457.54
96523 <1% 16 $433.68
83630 <1% 26 $423.60
84156 <1% 142 $415.66
29581 <1% 46 $369.66
85045 <1% 110 $359.58
86376 <1% 34 $349.20
81511 <1% 389 $338.87
86038 <1% 45 $338.52
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,101 $317.49
J3370 Injection, vancomycin hcl, 500 mg <1% 50 $312.64
C9290 Injection, bupivacaine liposome, 1 mg <1% 15 $262.57
J1790 Injection, droperidol, up to 5 mg <1% 42 $260.89
86308 <1% 51 $257.73
86215 <1% 19 $252.50
86304 <1% 17 $249.72
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 14,513 $241.33
82247 <1% 52 $237.16
83527 <1% 18 $233.82
85014 <1% 89 $232.66
85018 <1% 89 $232.66
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 4,198 $214.36
83525 <1% 18 $204.81
86039 <1% 18 $199.68
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 426 $191.47
87328 <1% 13 $179.66
82657 <1% 225 $179.48
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg <1% 13 $176.63
80299 <1% 13 $176.20
82105 <1% 17 $166.90
87329 <1% 13 $155.74
80183 <1% 16 $145.75
J0697 Injection, sterile cefuroxime sodium, per 750 mg <1% 3,523 $140.57
J0780 Injection, prochlorperazine, up to 10 mg <1% 15 $140.56
86060 <1% 19 $139.10
95249 <1% 13 $138.19
86706 <1% 12 $128.88
87102 <1% 12 $94.29
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 19 $94.14
C9113 Injection, pantoprazole sodium, per vial <1% 16 $84.42
83615 <1% 22 $79.88
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 14 $71.51
82248 <1% 15 $65.66
82947 <1% 24 $65.01
87206 <1% 12 $60.44
96361 Intravenous infusion, hydration; each additional hour <1% 44 $55.01
84550 <1% 12 $54.24
J2060 Injection, lorazepam, 2 mg <1% 14 $47.15
87209 <1% 15 $43.44
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen <1% 47 $35.95
87177 <1% 15 $18.50
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 135 $12.71
J7799 Noc drugs, other than inhalation drugs, administered through dme <1% 180 $11.80
81015 <1% 39 $3.05
0352U 0% 87 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialALEXANDER, STACY (CONTROLLER)
Same official

Other billing entities under ALEXANDER, STACY

Full network →
ProviderLocationPaid
Willis Knighton Medical Center, INC.Bossier City, LA$480K
Willis Knighton Medical Center INC. Crna GroupShreveport, LA$145K
Willis Knighton Medical Center, INC.Shreveport, LA$118K
Willis Knighton Medical Center, INC.Shreveport, LA$4K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.